
Are Photos Like Fingerprints? BIPA and Biometric Privacy Laws
Illinois’ BIPA is a model for upcoming biometric legislation; we expect 20% of states will have biometric privacy laws by 2024.
Illinois’ BIPA is a model for upcoming biometric legislation; we expect 20% of states will have biometric privacy laws by 2024.
The most recent Health IT vendor to settle with the government is a direct result of the DOJ’s new Civil Cyber-Fraud Initiative.
Quandary Peak’s review of FDA’s final guidance leads us to believe we could see meaningful expansion of the amount of CDSS qualifying as a medical device, which could subject many current and future CDS software applications to FDA oversight.
A standard approach for representing patient addresses across all health IT systems was needed to improve patient matching using accurate address information. Enter Project US@, the “Unified Specification for Address in Health Care.”
As medical devices evolve to better treat and monitor patient health, cybersecurity remains a top priority. As per FDA guidance, “medical device security is a shared responsibility…”
The FDA first drafted guidance on CDS software in 2017, but finalizing it has not been a priority for the agency since. That’s set to change next year.
The FDA has announced updated software guidance for Software in a Medical Device (SiMD) or Software as a Medical Device (SaMD).
The digitization of medical records should lead to streamlined access for patients, efficiency upgrades for providers, and economic opportunity for developers. These benefits exist in theory, but not in practice—due to cybersecurity concerns and the associated costs.
In a piecemeal regulatory environment, consumers will bear the brunt of the responsibility for vetting any app they choose to give access to their medical information. How that information is protected will be the province of third parties – until legislated otherwise.
DNA phenotyping has the potential for positive use cases for law enforcement, but it is still early days for the technology. As it evolves, it appears more information and review are necessary to come to a true conclusion about its efficacy – and to develop the guidelines and processes to safely use it.